TBPH Competitors & Alternatives
Compare Theravance Biopharma Inc with similar stocks in the same industry
Biotechnology
TBPH
Main Stock$17.03
Tradestie Score
51
Market Cap
$726.21M
P/E Ratio
16.4
Revenue Growth
-0.2%
Analyst Upside
+3.7%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$9.94
|
$906.29M | - | 51 | Compare |
|
NBTX
Nanobiotix S.A. American Depositary Shares
|
$33.18
|
$903.54M | - | 27 | Compare |
|
ORKA
Oruka Therapeutics, Inc. Common Stock
|
$105.24
|
$900.91M | - | 36 | Compare |
|
GERN
Geron Corp
|
$0.97
|
$899.60M | - | 65 | Compare |
|
ANAB
AnaptysBio, Inc. Common Stock
|
$48.28
|
$894.30M | - | 53 | Compare |
|
TNGX
Tango Therapeutics, Inc.
|
$24.51
|
$887.30M | - | 44 | Compare |
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$3.92
|
$879.90M | 3.4 | 56 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$10.38
|
$868.46M | - | 50 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$4.21
|
$867.49M | - | 48 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$19.98
|
$864.42M | - | 55 | Compare |
More TBPH Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry